-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 9th, Hisun Pharmaceutical announced that it received the "Drug Supplementary Application Approval Notice" for bicalutamide tablets approved and issued by the National Medical Products Administration.
Bicalutamide tablets are mainly suitable for the treatment of advanced prostate cancer.
According to statistics, the global sales of bicalutamide tablets in 2020 will be approximately US$394,949,200, of which China’s sales are approximately US$112,448,100 (data from the IMS database).